Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Dyslalia
ADR ID BADD_A07173
ADR Hierarchy
17      Nervous system disorders
17.02      Neurological disorders NEC
17.02.08      Speech and language abnormalities
17.02.08.018      Dyslalia
19      Psychiatric disorders
19.19      Communication disorders and disturbances
19.19.03      Speech articulation and rhythm disturbances
19.19.03.009      Dyslalia
Description Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language. [MeSH]
MedDRA Code 10013931
MeSH ID D013064
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dyslalia | Speech Disorders | Cluttering | Clutterings | Verbal Fluency Disorders | Verbal Fluency Disorder | Dyslalias | Rhinolalia | Rhinolalias | Aprosodia | Aprosodias | Aprosodic Speech | Speech, Aprosodic | Dysglossia | Dysglossias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00039Acyclovir0.000535%
BADD_D00121Amlodipine0.000006%
BADD_D00551Cyclosporine0.000166%
BADD_D01442Metoclopramide0.000196%
BADD_D01567Nilotinib0.000224%
BADD_D01633Oxaliplatin0.000224%
BADD_D01835Pregabalin0.000078%
BADD_D01888Quetiapine0.000055%
BADD_D01951Risperidone0.000121%
BADD_D02464Fingolimod0.000362%
BADD_D02553Entrectinib0.000112%
The 1th Page    1    Total 1 Pages